0,834  0,004  Tubulin antagonist
0,836  0,007  Caspase 9 stimulant
0,809  0,003  Alpha tubulin antagonist
0,805  0,004  UGT1A6 substrate
0,796  0,004  UGT1A9 substrate
0,793  0,008  Antineoplastic (colorectal cancer)
0,788  0,005  Aldehyde oxidase inhibitor
0,789  0,007  Antineoplastic (colon cancer)
0,773  0,011  Antineoplastic (lung cancer)
0,748  0,014  Antineoplastic (breast cancer)
0,733  0,004  Antimutagenic
0,716  0,009  Prostate cancer treatment
0,707  0,004  UGT1A3 substrate
0,702  0,004  Genotoxic
0,724  0,027  Apoptosis agonist
0,683  0,003  Beta tubulin antagonist
0,669  0,008  CTGF expression inhibitor
0,663  0,007  Antineoplastic (non-small cell lung cancer)
0,655  0,007  Caspase 3 stimulant
0,664  0,017  TNF expression inhibitor
0,653  0,006  Free radical scavenger
0,655  0,008  NOS2 expression inhibitor
0,632  0,006  Antimitotic
0,628  0,009  Antioxidant
0,628  0,010  Antineoplastic (melanoma)
0,618  0,014  Antineoplastic (ovarian cancer)
0,615  0,012  Antineoplastic (cervical cancer)
0,599  0,004  Peroxidase inhibitor
0,594  0,007  UDP-glucuronosyltransferase substrate
0,588  0,008  Amyloid beta aggregation inhibitor
0,591  0,025  15-Lipoxygenase inhibitor
0,575  0,010  Antineoplastic (glioma)
0,575  0,015  5 Hydroxytryptamine release inhibitor
0,563  0,005  UGT2B4 substrate
0,558  0,003  Carcinogenic, group 1
0,583  0,033  Transcription factor NF kappa B inhibitor
0,564  0,017  CYP1A2 substrate
0,551  0,005  Topoisomerase II inhibitor
0,549  0,003  Cystathionine beta-synthase inhibitor
0,557  0,015  Cytostatic
0,562  0,029  GST A substrate
0,542  0,011  Hypoxia-inducible factor 1 alpha inhibitor
0,535  0,005  Antineoplastic (squamous cell carcinoma)
0,533  0,004  UGT2B15 substrate
0,533  0,008  Antineoplastic (carcinoma)
0,533  0,010  Antineoplastic (glioblastoma multiforme)
0,544  0,021  5 Hydroxytryptamine release stimulant
0,534  0,012  CYP1A2 inhibitor
0,529  0,010  Superoxide dismutase inhibitor
0,553  0,034  Antineoplastic (solid tumors)
0,526  0,009  UGT1A1 substrate
0,530  0,018  Cardioprotectant
0,541  0,033  Antileukemic
0,520  0,018  AR expression inhibitor
0,498  0,004  Pneumotoxic
0,505  0,018  Lipoxygenase inhibitor
0,490  0,005  Antineoplastic (gastric cancer)
0,490  0,007  Antiseptic
0,509  0,030  Antipruritic, allergic
0,512  0,034  CYP2C9 substrate
0,496  0,020  Cardiovascular analeptic
0,483  0,010  Antineoplastic (lymphocytic leukemia)
0,493  0,022  12-Lipoxygenase inhibitor
0,492  0,021  Mutagenic
0,476  0,006  Amylase inhibitor
0,483  0,017  Antipyretic
0,493  0,031  Histamine release inhibitor
0,481  0,020  Antineoplastic (multiple myeloma)
0,456  0,006  GST M1-1 substrate
0,455  0,010  UGT1A4 substrate
0,486  0,043  CYP3A4 substrate
0,448  0,005  Tyrosine 3 hydroxylase inhibitor
0,464  0,022  Chemopreventive
0,459  0,018  DNA damaging
0,472  0,032  CYP2C19 inhibitor
0,469  0,031  Ulceration
0,439  0,012  Antineoplastic (sarcoma)
0,451  0,028  Antineoplastic (pancreatic cancer)
0,450  0,028  Antineoplastic (brain cancer)
0,430  0,010  Skin whitener
0,436  0,017  Antineoplastic (renal cancer)
0,433  0,015  Calcium channel activator
0,423  0,008  VCAM1 expression inhibitor
0,433  0,022  Tumour necrosis factor alpha release inhibitor
0,424  0,013  Antineoplastic (bladder cancer)
0,412  0,005  Topoisomerase II alpha inhibitor
0,412  0,007  Sulfotransferase substrate
0,433  0,029  Carcinogenic
0,420  0,016  RNA-directed DNA polymerase inhibitor
0,445  0,042  Vasodilator, peripheral
0,431  0,031  Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor
0,425  0,025  Antiamyloidogenic
0,484  0,085  Alpha-glucosidase inhibitor
0,436  0,038  Respiratory analeptic
0,434  0,037  Antihypercholesterolemic
0,404  0,008  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,447  0,052  Calcium channel L-type activator
0,408  0,015  Sodium/bile acid cotransporter inhibitor
0,425  0,037  CYP2C19 substrate
0,418  0,032  Chemoprotective
0,390  0,006  CYP2B6 inhibitor
0,425  0,043  Bone diseases treatment
0,400  0,021  Antihypertriglyceridemic
0,404  0,028  Proliferative diseases treatment
0,381  0,006  Topoisomerase I inhibitor
0,423  0,052  GABA C receptor rho-3 antagonist
0,381  0,010  GST P1-1 substrate
0,383  0,013  UGT2B7 substrate
0,406  0,036  Analeptic
0,391  0,021  Antineoplastic (small cell lung cancer)
0,371  0,011  Lipid peroxidase inhibitor
0,393  0,039  Antiosteoporotic
0,371  0,017  Non-steroidal antiinflammatory agent
0,366  0,012  DNA methyltransferase I inhibitor
0,391  0,039  Aryl hydrocarbon receptor agonist
0,364  0,015  Melanin inhibitor
0,357  0,008  Glutathione S-transferase substrate
0,368  0,021  5 Hydroxytryptamine uptake stimulant
0,352  0,005  Estrogen receptor beta antagonist
0,402  0,057  CYP2C9 inhibitor
0,372  0,029  Nitric oxide antagonist
0,350  0,007  NADPH oxidase inhibitor
0,364  0,029  Pyruvate kinase inhibitor
0,369  0,040  Cytotoxic
0,380  0,051  FMO1 substrate
0,374  0,047  Teratogen
0,346  0,020  Hepatoprotectant
0,372  0,046  Radioprotector
0,330  0,005  Estrogen antagonist
0,341  0,018  DNA methylase inhibitor
0,375  0,055  Cholesterol antagonist
0,341  0,022  P-glycoprotein inhibitor
0,345  0,027  Cyclic AMP phosphodiesterase inhibitor
0,326  0,007  Succinate dehydrogenase inhibitor
0,355  0,038  Antihypoxic
0,319  0,004  UGT2B10 substrate
0,328  0,014  NOS3 expression enhancer
0,341  0,036  Vasodilator
0,345  0,041  Antineoplastic (osteosarcoma)
0,311  0,008  UGT2B1 substrate
0,315  0,014  Neurotrophic factor enhancer
0,343  0,042  Radiosensitizer
0,356  0,057  Hepatic disorders treatment
0,336  0,041  Antineoplastic (lymphoma)
0,333  0,039  Transcription factor STAT3 inhibitor
0,350  0,057  CYP2D6 substrate
0,303  0,011  Nitric-oxide synthase stimulant
0,333  0,041  Antidiabetic symptomatic
0,297  0,005  Protein kinase C zeta inhibitor
0,342  0,051  Embryotoxic
0,295  0,005  HIV-1 integrase (3'-Processing) inhibitor
0,295  0,005  Toll-Like receptor 2 antagonist
0,320  0,031  Abortion inducer
0,297  0,008  LDLR expression enhancer
0,356  0,069  Angiogenesis inhibitor
0,302  0,018  Monophenol monooxygenase inhibitor
0,340  0,057  NOS3 expression inhibitor
0,341  0,060  Apoptosis antagonist
0,326  0,049  Sensitization
0,290  0,014  Antineoplastic (bone cancer)
0,317  0,043  Vascular (periferal) disease treatment
0,320  0,046  Cardiodepressant
0,278  0,007  SULT1A1 substrate
0,406  0,136  Antiinflammatory
0,274  0,005  HIV-1 integrase (Strand Transfer) inhibitor
0,277  0,011  Gout treatment
0,318  0,053  FMO3 substrate
0,314  0,050  Antiprotozoal (Leishmania)
0,269  0,005  Estrogen agonist
0,312  0,049  Transcription factor STAT inhibitor
0,345  0,084  Prostaglandin dehydrogenase inhibitor
0,268  0,008  VEGF expression inhibitor
0,278  0,023  Tumour necrosis factor antagonist
0,270  0,015  Heat shock protein 90 antagonist
0,353  0,100  Antibacterial
0,270  0,020  Antidote
0,252  0,003  Topoisomerase II beta inhibitor
0,254  0,007  Coagulant
0,282  0,037  Antihypotensive
0,249  0,006  Photosensitizer
0,247  0,005  Carcinogenic, group 2A
0,255  0,015  5-Lipoxygenase inhibitor
0,316  0,075  Vasodilator, coronary
0,258  0,019  Acetylcholinesterase inhibitor
0,250  0,012  Xanthine oxidase inhibitor
0,244  0,007  CF transmembrane conductance regulator agonist
0,330  0,097  Immunosuppressant
0,304  0,071  Antineoplastic (endocrine cancer)
0,248  0,016  DNA intercalator
0,275  0,043  Antineoplastic enhancer
0,240  0,009  Carbonic anhydrase XIII inhibitor
0,238  0,008  Protein kinase C gamma inhibitor
0,237  0,009  Carbonic anhydrase VI inhibitor
0,244  0,017  SULT1A3 substrate
0,284  0,059  Hypoglycemic
0,234  0,011  Carbonic anhydrase III inhibitor
0,295  0,072  Spasmolytic
0,249  0,027  Heat shock protein 90 alpha antagonist
0,279  0,060  Antineoplastic (liver cancer)
0,228  0,010  Histidine decarboxylase inhibitor
0,304  0,087  ICAM1 expression inhibitor
0,236  0,020  Hexokinase inhibitor
0,231  0,015  Expectorant
0,232  0,016  GABA C receptor rho-2 antagonist
0,238  0,024  UGT2B9 substrate
0,230  0,021  Cholesterol synthesis inhibitor
0,298  0,089  Antithrombotic
0,245  0,038  Mcl-1 antagonist
0,237  0,030  Carcinogenic, group 3
0,213  0,007  Macrophage migration inhibitory factor inhibitor
0,231  0,025  M18 aspartyl aminopeptidase inhibitor
0,224  0,019  Mannose-6-phosphate isomerase inhibitor
0,230  0,025  Cyclooxygenase 1 inhibitor
0,214  0,010  Dopamine D1 antagonist
0,209  0,005  DOPA decarboxylase inhibitor
0,211  0,008  Antineoplastic (uterine cancer)
0,233  0,031  Protein kinase stimulant
0,234  0,033  Histone acetyltransferase inhibitor
0,262  0,062  5 Hydroxytryptamine 1E antagonist
0,222  0,023  ATPase inhibitor
0,262  0,063  Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor
0,222  0,024  Antifungal enhancer
0,206  0,009  NAD(P)H dehydrogenase (quinone) inhibitor
0,225  0,029  Aldehyde oxidase substrate
0,215  0,022  Alkylator
0,196  0,005  Estrogen receptor alpha agonist
0,203  0,013  Antineoplastic alkaloid
0,204  0,014  Antihelmintic (Trematoda)
0,212  0,023  Arachidonic acid antagonist
0,190  0,005  UGT2B11 substrate
0,201  0,017  Choleretic
0,236  0,052  Antiviral (Influenza)
0,211  0,030  Neurotensin receptor agonist
0,193  0,014  Breast cancer-resistant protein inhibitor
0,189  0,011  Prolactin inhibitor
0,187  0,010  Keratolytic
0,208  0,030  Alkaline phosphatase inhibitor
0,211  0,034  Neuropathy treatment
0,202  0,027  DNA polymerase I inhibitor
0,187  0,013  Creatine kinase inhibitor
0,253  0,081  Antiprotozoal (Trypanosoma)
0,195  0,024  Interleukin 4 antagonist
0,221  0,051  Dual specificity phosphatase 3 inhibitor
0,188  0,017  NAT2 substrate
0,190  0,020  Carbonic anhydrase XV inhibitor
0,174  0,005  Estrogen receptor beta agonist
0,269  0,100  CYP3A4 inhibitor
0,227  0,061  Anesthetic general
0,176  0,009  SULT1E1 substrate
0,174  0,009  Aldose reductase inhibitor
0,241  0,076  Dyrk kinase inhibitor
0,188  0,023  Microtubule formation inhibitor
0,179  0,015  AMP-activated protein kinase stimulant
0,182  0,018  Gastritis treatment
0,188  0,024  Carcinogenic, group 2B
0,210  0,046  3C-like protease (Human coronavirus) inhibitor
0,167  0,004  Granulocyte macrophage colony stimulating factor agonist
0,171  0,009  Antifungal (Pneumocystis)
0,206  0,045  Protein kinase C nu inhibitor
0,184  0,023  Adenylate cyclase stimulant
0,178  0,019  Mucolytic
0,199  0,041  Skeletal muscle relaxant
0,211  0,054  Antipruritic, non-allergic
0,167  0,010  Estrogen receptor alpha antagonist
0,208  0,052  Muscle relaxant
0,182  0,026  Cyclooxygenase 3 inhibitor
0,173  0,018  Protein kinase C mu inhibitor
0,195  0,041  Uterine stimulant
0,189  0,037  Hemostatic
0,231  0,079  Angiogenesis stimulant
0,196  0,044  Antirickettsial
0,195  0,044  Cyclooxygenase inhibitor
0,169  0,018  Antiviral (Influenza B)
0,161  0,011  Acetylcholine release stimulant
0,160  0,011  Paget's disease treatment
0,172  0,024  Bronchodilator
0,179  0,031  Antieczematic
0,168  0,021  Antihelmintic (Fasciola)
0,231  0,086  Myocardial infarction treatment
0,196  0,053  Eye irritation, high
0,164  0,021  DNA repair enzyme inhibitor
0,154  0,012  Postmenopausal disorders treatment
0,162  0,019  Arylamine N-Acetyltransferase substrate
0,146  0,004  Estradiol 17 beta-dehydrogenase 2 inhibitor
0,148  0,006  Estradiol 17 beta-dehydrogenase inhibitor
0,146  0,005  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,250  0,109  Antifungal
0,161  0,021  Multidrug resistance-associated protein 1 inhibitor
0,243  0,103  Insulysin inhibitor
0,233  0,094  Flavin-containing monooxygenase substrate
0,162  0,025  Heat shock protein 70 antagonist
0,154  0,018  Phosphodiesterase 4D inhibitor
0,217  0,082  Antiviral (West Nile virus)
0,187  0,052  Protein-tyrosine phosphatase inhibitor
0,186  0,053  Cholinergic
0,212  0,079  Antiparasitic
0,140  0,008  SULT1A2 substrate
0,182  0,049  Interferon gamma antagonist
0,170  0,037  Aldehyde dehydrogenase inhibitor
0,189  0,057  Liver fibrosis treatment
0,275  0,142  Antiprotozoal
0,145  0,014  Glutamate decarboxylase inhibitor
0,140  0,010  HIV-1 integrase inhibitor
0,197  0,067  Antiviral (Ebola)
0,142  0,012  Glutamate release inhibitor
0,143  0,014  CDC25A inhibitor
0,166  0,037  Antitussive
0,165  0,036  Antihemorrhagic
0,152  0,024  HIV-1 integrase (Overall Integration) inhibitor
0,159  0,033  Chelator
0,179  0,053  Catenin beta inhibitor
0,198  0,072  Platelet adhesion inhibitor
0,149  0,024  Myasthenia Gravis treatment
0,182  0,057  Muscular dystrophy treatment
0,180  0,054  Antiviral (Influenza A)
0,187  0,062  Dual specificity phosphatase inhibitor
0,189  0,065  Amyloid beta precursor protein antagonist
0,181  0,057  Phobic disorders treatment
0,155  0,031  Ca2+-transporting ATPase inhibitor
0,169  0,047  Bone formation stimulant
0,144  0,023  Antiprotozoal (Toxoplasma)
0,152  0,032  Papain-like protease (SARS coronavirus) inhibitor
0,169  0,050  Antiprotozoal (Coccidial)
0,127  0,008  Dopamine D2 agonist
0,196  0,078  Insulin sensitizer
0,170  0,053  Aldose reductase substrate
0,165  0,047  Alpha-N-acetylglucosaminidase inhibitor
0,130  0,013  Alcohol oxidase inhibitor
0,124  0,008  Estrogen-related receptor beta agonist
0,200  0,085  Antialcoholic
0,161  0,047  Cyclooxygenase 2 inhibitor
0,151  0,038  Vanilloid 1 agonist
0,138  0,025  Alcohol dehydrogenase inhibitor
0,147  0,036  Contraceptive female
0,123  0,012  Protein kinase C eta inhibitor
0,123  0,012  D-Ala-D-Ala ligase inhibitor
0,250  0,139  Antiprotozoal (Plasmodium)
0,117  0,007  Heat shock protein 90 beta antagonist
0,128  0,018  Dopamine agonist
0,125  0,016  ATPase (Vacuolar H+) inhibitor
0,130  0,022  Antidote, mercury
0,154  0,046  Antihyperlipoproteinemic
0,178  0,070  Sigma receptor agonist
0,118  0,011  Xanthine dehydrogenase inhibitor
0,137  0,030  Urease inhibitor
0,146  0,040  Alpha 2b adrenoreceptor antagonist
0,197  0,093  ErbB-1 antagonist
0,121  0,018  Aromatase inhibitor
0,172  0,070  Phospholipase C inhibitor
0,181  0,079  Antihelmintic
0,116  0,014  Narcotic antagonist
0,130  0,029  Androgen antagonist
0,130  0,029  Phosphodiesterase IV inhibitor
0,138  0,039  Butyrylcholinesterase inhibitor
0,151  0,055  Toll-Like receptor antagonist
0,129  0,033  GABA C receptor rho-1 antagonist
0,119  0,024  Tocolytic
0,115  0,020  Phenylalanine 4-hydroxylase inhibitor
0,122  0,027  NADH dehydrogenase inhibitor
0,131  0,036  Beta glucuronidase inhibitor
0,137  0,043  Endometrios treatment
0,101  0,008  SULT2A1 substrate
0,146  0,054  Antiprotozoal (Trichomonas)
0,105  0,013  Endocannabinoid uptake inhibitor
0,128  0,036  Sphingomyelinase inhibitor
0,112  0,020  Thioredoxin reductase inhibitor
0,097  0,007  Postcoital contraceptive
0,128  0,037  Chronic obstructive bronchitis treatment
0,140  0,050  Protein-tyrosine phosphatase 1B inhibitor
0,126  0,038  Toll-Like receptor 4 antagonist
0,091  0,005  Dopamine D5 agonist
0,149  0,062  MAP3K9 inhibitor
0,146  0,060  Pregnane X receptor agonist
0,136  0,050  Antiviral (Papilloma)
0,147  0,062  MAO inhibitor
0,122  0,037  Anabolic
0,110  0,024  Glycine receptor antagonist
0,132  0,047  MAO A inhibitor
0,150  0,066  Antiparkinsonian, tremor relieving
0,096  0,013  Glutamate (mGluR7) antagonist
0,099  0,017  GABA B receptor agonist
0,091  0,009  Transcription factor RelA inhibitor
0,155  0,074  Antiviral (Herpes)
0,102  0,021  Phosphodiesterase III inhibitor
0,085  0,004  Estradiol 17 beta-dehydrogenase 1 inhibitor
0,119  0,039  Antineoplastic antibiotic
0,129  0,048  Excitatory amino acid transporter EAAC1 inhibitor
0,086  0,006  Ryanodine receptor antagonist
0,164  0,084  Toxic, respiratory center
0,201  0,122  DNA synthesis inhibitor
0,107  0,028  Myeloperoxidase inhibitor
0,087  0,008  DNA helicase inhibitor
0,118  0,039  Uric acid excretion stimulant
0,263  0,185  DNA polymerase beta inhibitor
0,122  0,044  Electron transport complex I inhibitor
0,088  0,010  Dopamine D5 antagonist
0,173  0,096  I kappa B kinase epsilon inhibitor
0,105  0,028  mTOR complex 2 inhibitor
0,095  0,018  Antidote, heavy metal
0,115  0,039  Antifungal (Aspergillus)
0,123  0,047  Alpha 2c adrenoreceptor antagonist
0,084  0,010  Glucose-6-phosphate translocase inhibitor
0,124  0,049  GABA C receptor antagonist
0,117  0,043  GST T1-1 substrate
0,125  0,052  5 Hydroxytryptamine 3A agonist
0,093  0,020  MAP kinase kinase 7 inhibitor
0,128  0,056  Skin irritative effect
0,145  0,072  Antianemic
0,091  0,020  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,120  0,049  GABA C receptor agonist
0,143  0,072  Cell wall synthesis inhibitor
0,128  0,057  Retinopathy treatment
0,089  0,018  Beta 3 adrenoreceptor antagonist
0,124  0,054  TRPA1 agonist
0,193  0,124  Immunostimulant
0,082  0,013  Calcium channel P-type blocker
0,115  0,047  UDP-glucose 4-epimerase inhibitor
0,080  0,013  5 Hydroxytryptamine 7 agonist
0,082  0,016  Carbonic anhydrase XIV inhibitor
0,141  0,075  Hair growth stimulant
0,088  0,022  Beta adrenoreceptor antagonist
0,116  0,051  Mediator release inhibitor
0,097  0,032  Purinergic P2X2 antagonist
0,136  0,072  Psychosexual dysfunction treatment
0,104  0,040  Phosphodiesterase I inhibitor
0,105  0,042  Actinic keratosis treatment
0,072  0,010  Factor III inhibitor
0,139  0,076  Activin receptor-like kinase 2 inhibitor
0,085  0,024  Protein kinase C beta inhibitor
0,140  0,079  Acaricide
0,067  0,006  Melatonin 2 agonist
0,069  0,009  Liver X receptor alpha agonist
0,148  0,089  Antihelmintic (Nematodes)
0,117  0,059  Aldehyde dehydrogenase substrate
0,128  0,070  Antibacterial (Helicobacter pylori)
0,140  0,083  MAP kinase kinase 4 inhibitor
0,140  0,083  Cytidine deaminase inhibitor
0,088  0,032  Carbonic anhydrase V inhibitor
0,143  0,087  Ca2+/calmodulin-dependent protein kinase kinase B inhibitor
0,193  0,138  Streptokinase A inhibitor
0,089  0,034  Lipase inhibitor
0,155  0,101  Sedative
0,086  0,032  Carbonic anhydrase VA inhibitor
0,068  0,015  Squalene epoxidase inhibitor
0,101  0,049  Phosphodiesterase 6D inhibitor
0,098  0,047  Ornithine decarboxylase inhibitor
0,057  0,007  Nucleoside transporters inhibitor
0,085  0,036  Antidote, organophosphates
0,084  0,034  Glycine receptor agonist
0,126  0,077  Cocaine dependence treatment
0,053  0,005  Estrogen-related receptor beta antagonist
0,089  0,042  Na+ K+ transporting ATPase inhibitor
0,099  0,051  Bile acid receptor antagonist
0,075  0,027  Androgen agonist
0,065  0,018  Anesthetic inhalation
0,089  0,043  Alpha 2a adrenoreceptor antagonist
0,093  0,047  Antispirochetal
0,173  0,127  5 Hydroxytryptamine 3E antagonist
0,116  0,071  Beta amyloid protein antagonist
0,091  0,048  Antiviral (Trachoma)
0,071  0,028  Phosphodiesterase 1C inhibitor
0,047  0,005  Dopamine D1 agonist
0,240  0,198  DNA directed DNA polymerase inhibitor
0,088  0,049  Platelet growth factor antagonist
0,063  0,024  Pregnane X receptor antagonist
0,167  0,130  Antiviral (HIV)
0,088  0,050  Glutathione S-transferase inhibitor
0,080  0,044  NAT1 substrate
0,161  0,125  Antiparkinsonian, rigidity relieving
0,068  0,032  Phosphodiesterase 1B inhibitor
0,121  0,085  Toll-Like receptor 9 antagonist
0,047  0,011  Vanilloid 3 antagonist
0,058  0,022  Potassium channel Kv1.3 blocker
0,066  0,030  Beta 1 adrenoreceptor antagonist
0,093  0,057  Thioredoxin inhibitor
0,111  0,075  Interleukin 8 antagonist
0,081  0,046  GABA aminotransferase inhibitor
0,075  0,040  Leukotriene synthesis inhibitor
0,081  0,047  Catalase inhibitor
0,059  0,025  Beta 2 adrenoreceptor antagonist
0,057  0,024  CD45 antagonist
0,258  0,224  MAP kinase 1 inhibitor
0,055  0,022  Dopamine beta hydroxylase inhibitor
0,058  0,025  Antibiotic Glycopeptide-like
0,070  0,038  CDC25B inhibitor
0,064  0,032  Carbonic anhydrase VB inhibitor
0,043  0,011  Melatonin receptor 1A agonist
0,083  0,051  Phosphodiesterase 3A inhibitor
0,094  0,064  Platelet activating factor alpha antagonist
0,078  0,047  Antitreponemal
0,048  0,018  3-Hydroxyanthranilate 3,4-dioxygenase inhibitor
0,033  0,005  Ileal bile acid transport inhibitor
0,087  0,058  Alpha 2 adrenoreceptor antagonist
0,090  0,062  Restless leg syndrome treatment
0,044  0,017  Phosphoglycerate kinase inhibitor
0,128  0,101  Restenosis treatment
0,056  0,029  Vanilloid 2 antagonist
0,064  0,038  5 Hydroxytryptamine 5A antagonist
0,090  0,063  Protein kinase C delta inhibitor
0,041  0,014  Melatonin agonist
0,040  0,015  Tubulin agonist
0,057  0,032  Leukotriene B4 antagonist
0,158  0,133  Ca2+/calmodulin-dependent kinase I alpha inhibitor
0,069  0,044  Exportin-1 inhibitor
0,045  0,020  Alpha 1d adrenoreceptor agonist
0,065  0,040  Antiviral (Parainfluenza)
0,075  0,051  Porphobilinogen synthase inhibitor
0,145  0,121  Antiarrhythmic
0,063  0,039  Transcription factor AP-1 inhibitor
0,090  0,066  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,040  0,017  Estrogen-related receptor alpha antagonist
0,068  0,044  Glutamate (mGluR6) antagonist
0,039  0,016  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,060  0,037  5 Hydroxytryptamine 5 antagonist
0,039  0,016  Melatonin 1 agonist
0,066  0,044  Uterine relaxant
0,062  0,040  Enoyl-[acyl-carrier-protein] reductase inhibitor
0,122  0,100  Farnesoid X receptor antagonist
0,083  0,061  Calcium antagonist
0,089  0,067  ABCA1 expression enhancer
0,089  0,067  MAO B inhibitor
0,081  0,060  CC chemokine 5 receptor agonist
0,058  0,037  Fatty acid synthase inhibitor
0,037  0,017  Catechol O-methyltransferase inhibitor
0,071  0,051  Telomerase inhibitor
0,086  0,066  Triose-phosphate isomerase inhibitor
0,185  0,166  CYP2D6 inhibitor
0,038  0,018  Sodium-dependent vitamin C transporter 2 inhibitor
0,046  0,026  Dihydrofolate reductase inhibitor
0,062  0,043  5 Hydroxytryptamine 7 antagonist
0,049  0,029  Carbonic anhydrase VII inhibitor
0,061  0,042  Purinergic P2X1 antagonist
0,073  0,054  Phosphodiesterase VI inhibitor
0,055  0,038  Sphingosine kinase 2 inhibitor
0,068  0,051  Anticholelithogenic
0,168  0,150  Interleukin agonist
0,055  0,038  Immunoglobulin Fc receptor antagonist
0,049  0,032  Glucose-6-phosphate isomerase inhibitor
0,110  0,094  Contraceptive
0,078  0,062  Protein kinase A inhibitor
0,029  0,014  Hedgehog signaling activator
0,034  0,019  GABA transporter 3 inhibitor
0,022  0,007  Antibiotic Anthracycline-like
0,063  0,048  Neuraminidase (influenza) inhibitor
0,101  0,087  Antiviral (Coronavirus)
0,101  0,087  Antiviral (SARS coronavirus)
0,054  0,040  Phosphodiesterase 4C inhibitor
0,045  0,031  Neuraminidase (Influenza A) inhibitor
0,107  0,093  Alcohol dehydrogenase substrate
0,123  0,110  Antidiarrheal
0,029  0,017  Estrogen-related receptor gamma antagonist
0,060  0,047  5 Hydroxytryptamine 2A agonist
0,058  0,046  Bcl-xL inhibitor
0,066  0,055  Andropause treatment
0,032  0,021  ATP citrate lysase inhibitor
0,092  0,082  Adenylate kinase inhibitor
0,051  0,041  Heparanase inhibitor
0,060  0,050  Beta 2 adrenoreceptor agonist
0,101  0,092  Antiprotozoal (Babesia)
0,147  0,138  Proto-oncogene tyrosine-protein kinase Fyn inhibitor
0,063  0,054  Phosphofructokinase-1 inhibitor
0,087  0,078  Lanosterol 14 alpha demethylase inhibitor
0,048  0,040  5 Hydroxytryptamine 2 agonist
0,121  0,113  CC chemokine 6 receptor antagonist
0,041  0,034  Phosphodiesterase 3B inhibitor
0,065  0,058  Dopamine antagonist
0,058  0,051  Antimycoplasmal
0,079  0,073  Vanilloid agonist
0,073  0,067  Adrenaline agonist
0,031  0,026  Liver X receptor beta agonist
0,032  0,027  Progesterone antagonist
0,105  0,100  Antiprotozoal (Amoeba)
0,113  0,108  Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor
0,027  0,022  Liver X receptor beta antagonist
0,044  0,040  Phosphodiesterase 4A inhibitor
0,065  0,062  Antibiotic
0,106  0,103  Sphingosine 1-phosphate receptor 4 antagonist
0,041  0,038  Fructose-1,6-bisphosphatase inhibitor
0,047  0,045  Aconitate hydratase inhibitor
0,162  0,160  Lipoprotein disorders treatment
0,035  0,034  Vesicle monoamine transporter inhibitor
0,057  0,056  Heme oxygenase stimulant
0,177  0,176  Antimycobacterial
0,009  0,008  Progesterone receptor A antagonist
0,054  0,054  Dopamine D2 antagonist
0,030  0,030  Glutamate (mGluR3) agonist
0,035  0,035  Glutamate (mGluR8) agonist
0,024  0,024  Sodium/glucose cotransporter 2 inhibitor

